News
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
8 July 2026
OGB Merah at HISFARSI 2026: Reflecting Quality, Strengthening Trust
The quality of generic medicines can be demonstrated both through the production process and through the trust placed in them by healthcare professionals who use them in their practice. Building on this commitment, PT Dexa Medica presented "OGB Merah, A Reflection of Quality Generic Medicine" at the HISFARSI 2026 National…
28 August 2018
Dexa Medica Wins Indonesia Corporate PR Award 2018
PT Dexa Medica received an award for its Corporate Public Relations performance through the Indonesia Corporate PR Award 2018, organized by the International Public Relations Association: IPRA in collaboration with Warta Ekonomi on Friday, August 24, 2018. This award was handed over directly by the former Minister of Maritime Affairs…
15 August 2018
Glucient SR, Top Indonesia Global Brands 2018
Glucient SR, Top Indonesia Global Brands 2018 Glucient SR, a product from PT Ferron Par Pharmaceuticals, selected to be Top Original Brands from Indonesia in SWA magazine edition on August 2018. Glucient SR selected to be the Top 25 Indonesia Global Brands 2018 category which is one of the best…
4 July 2018
Dexa Medica’s Director of Innovation and Scientific Development Wins SINTA Awards 2018
Director of Innovation and Scientific Development of PT Dexa Medica, Raymond R. Tjandrawinata, Ph.D., M.S., MBA has taken home the SINTA (Science and Technology Index) Awards 2018 in the Author Category of the Scientific Publication with the highest SINTA Score for Private University Category on Wednesday, 4 July 2018. SINTA…
11 May 2018
Dexa Medica Wins IMACO 2018
PT Dexa Medica has been awarded as the Innovative Company in Pharmaceutical Sector at the Indonesia Most Admired Companies (IMACO) Award 2018—becoming the only pharmaceutical company to receive the award. According to research conducted by Warta Ekonomi Research and Consulting (WERC), the company scored the highest brand awareness and the…
3 May 2018
Ferron Wins “The Outstanding Corporate Innovator Award 2018”
PT Ferron Par Pharmaceuticals at The 4th Outstanding Corporate Innovator (OCI) Award 2018 won the 2018 Platinum Award, Shangri-la Hotel, Jakarta, on Wednesday, April 2 2018. The award was given by the Executive Director of PPM Manajemen Bramantyo Djohanputro to the President Director of PT Ferron Par Pharmaceuticals Krestijanto Pandji.…
26 April 2018
Vice President of Indonesia Presented WIPO Award 2018 to DLBS Executive Director
Dexa Laboratories of Biomolecular Sciences (DLBS) Executive Director, Raymond R Tjandrawinata, Ph.D., MS, MBA has been awarded a WIPO Medal for Inventors at the World Intellectual Property Organization (WIPO) Award 2018 held in the Vice Presidential Palace on Thursday, 26 April 2018. This award was presented directly by the Vice…
20 April 2018
Dexa Medica Receives First Acknowledgement for the Year 2018
Dexa Medica received another Certificate of Appreciation for the third time through its CSR activities in West Java implemented throughout 2017. The company received not only the certificate but also an award plaque for its sustainable health education program in 13 villages which has been running since 2016 in collaboration…